Body Mass Index and Nutritional Dynamics as Predictors of Survival in Patients with Oropharyngeal Squamous Cell Carcinoma Undergoing Chemoradiation
Authors:
Open Access
- 20 October 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8142
Abstract
Background/Objective: Body mass index (BMI) and treatment-related weight variation have been increasingly investigated as potential prognostic factors in head and neck oncology. However, their role in patients with oropharyngeal squamous cell carcinoma (OPSCC) undergoing concomitant chemoradiation (CRT) remains incompletely defined, particularly in real-world Eastern European populations. The aim of this study was to evaluate the prognostic significance of pretreatment BMI and treatment-induced weight variation in patients with OPSCC treated with curative-intent CRT and to assess their association with survival outcomes. Methods: This single-centre retrospective cohort study evaluated consecutive patients with OPSCC treated with CRT at a Romanian regional oncology centre between 2015 and 2023. Key exclusions were prior surgery or neoadjuvant chemotherapy, palliative care, and secondary malignancies. Clinical variables, baseline comorbidity burden (via Age-Adjusted Charlson Comorbidity Index), and body mass index (BMI) dynamics across treatment timepoints—including pre- and post-CRT BMI, ΔBMI during CRT, and weight loss thresholds ≥5% and ≥10%—were assessed. Overall survival (OS) was analysed using Kaplan–Meier curves, log-rank tests, and Cox proportional hazards multivariate regression to determine independent prognostic factors (p p = 0.01), CRT duration ≥ 47 days (63.2% vs. 92.3%; HR 2.52, p = 0.05), weight loss ≥ 10% (50.0% vs. 71.6%; HR 2.28, p = 0.03), pre-CRT BMI < 24 kg/m2 (HR 0.50, p = 0.04), post-CRT BMI < 24 kg/m2 (HR 0.40, p < 0.01), and a BMI reduction > 6% (HR 0.50, p = 0.03). On multivariate Cox regression, only age at diagnosis and CRT treatment duration were validated as independent prognostic factors for OS. Conclusions: Weight loss during concomitant CRT and low body mass index were associated with impaired 5-year OS in patients with oropharyngeal squamous cell carcinoma. However, after multivariate adjustment, age at diagnosis, and treatment duration were the sole independent prognostic factors.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence and risk factors for critical weight loss among patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysisEuropean Journal of Oncology Nursing, 2025
- Impact of radiotherapy on body weight in head and neck cancer patients: A prospective studyClinical Nutrition ESPEN, 2024
- Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapyJAMA Network Open, 2023
- Association of Body Mass Index with Survival Outcome in Patients with Head and Neck Cancer Treated with Combined Modality TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinomaHead & Neck, 2021
- The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/− systemic therapy in locally advanced head and neck cancerJournal of Geriatric Oncology, 2021
- The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaOral Oncology, 2016
- Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell CarcinomaJAMA Oncology, 2016
- Impact of Pretreatment Body Mass Index on Patients With Head-and-Neck Cancer Treated With RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012